Hillhouse Capital Advisors
Latest statistics and disclosures from Hhlr Advisors's latest quarterly 13F-HR filing:
- Top 5 stock holdings are Beigene, BABA, PDD, NTES, BEKE, and represent 63.05% of Hhlr Advisors's stock portfolio.
- Added to shares of these 10 stocks: WNS (+$73M), API (+$8.7M), BEKE (+$7.2M), FUTU (+$5.4M), TSM, JD, MSCI, MCO, DHR, GE.
- Started 5 new stock positions in WNS, MSCI, Lakeshore Biopharma, MOMO, API.
- Reduced shares in these 10 stocks: BABA (-$334M), Beigene (-$254M), PDD (-$198M), TCOM (-$59M), ZTO (-$50M), BIDU (-$32M), YUMC (-$30M), LEGN (-$21M), HTHT (-$21M), VIPS (-$11M).
- Sold out of its positions in BIDU, META, URA, HTHT, KWEB, YUMC, ZK, LSB.
- Hhlr Advisors was a net seller of stock by $-917M.
- Hhlr Advisors has $2.9B in assets under management (AUM), dropping by -36.62%.
- Central Index Key (CIK): 0001762304
Tip: Access up to 7 years of quarterly data
Positions held by Hillhouse Capital Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Hhlr Advisors
Hhlr Advisors holds 45 positions in its portfolio as reported in the December 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Beigene Sponsored Adr | 24.3 | $703M | -26% | 3.8M | 184.71 |
|
| Alibaba Group Hldg Sponsored Ads (BABA) | 14.4 | $414M | -44% | 4.9M | 84.79 |
|
| Pdd Holdings Sponsored Ads (PDD) | 9.2 | $265M | -42% | 2.7M | 96.99 |
|
| Netease Sponsored Ads (NTES) | 8.0 | $231M | 2.6M | 89.21 |
|
|
| Ke Hldgs Sponsored Ads (BEKE) | 7.2 | $207M | +3% | 11M | 18.42 |
|
| Vipshop Hldgs Sponsored Ads A (VIPS) | 6.9 | $200M | -5% | 15M | 13.47 |
|
| Legend Biotech Corp Sponsored Ads (LEGN) | 6.7 | $195M | -9% | 6.0M | 32.54 |
|
| Arrivent Biopharma (AVBP) | 4.1 | $120M | 4.5M | 26.64 |
|
|
| Futu Hldgs Spon Ads Cl A (FUTU) | 3.1 | $90M | +6% | 1.1M | 79.99 |
|
| WNS HLDGS Com Shs (WNS) | 2.5 | $73M | NEW | 1.5M | 47.39 |
|
| Trip Com Group Ads (TCOM) | 2.2 | $63M | -48% | 914k | 68.66 |
|
| Jd.com Spon Ads Cl A (JD) | 2.0 | $59M | +5% | 1.7M | 34.67 |
|
| Enfusion Cl A (ENFN) | 1.8 | $51M | 5.0M | 10.30 |
|
|
| Cytek Biosciences (CTKB) | 1.5 | $43M | 6.7M | 6.49 |
|
|
| Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA) | 1.1 | $31M | 1.6M | 19.78 |
|
|
| Bridgebio Pharma (BBIO) | 1.0 | $28M | 1.0M | 27.44 |
|
|
| Yatsen Hldg Sponsored Ads (YSG) | 0.9 | $27M | 6.9M | 3.98 |
|
|
| Contineum Therapeutics Cl A (CTNM) | 0.3 | $9.8M | 669k | 14.65 |
|
|
| Agora Ads (API) | 0.3 | $8.7M | NEW | 2.1M | 4.16 |
|
| Zto Express Cayman Sponsored Ads A (ZTO) | 0.3 | $8.5M | -85% | 436k | 19.55 |
|
| Taiwan Semiconductor Mfg Sponsored Ads (TSM) | 0.3 | $8.4M | +119% | 43k | 197.49 |
|
| Sohu Sponsored Ads (SOHU) | 0.2 | $6.7M | -28% | 511k | 13.18 |
|
| I Mab Sponsored Ads (IMAB) | 0.2 | $5.1M | -13% | 6.0M | 0.85 |
|
| Gossamer Bio (GOSS) | 0.2 | $4.5M | 5.0M | 0.90 |
|
|
| Sagimet Biosciences Com Ser A (SGMT) | 0.1 | $3.3M | 725k | 4.50 |
|
|
| Aligos Therapeutics Com New (ALGS) | 0.1 | $3.0M | 76k | 39.84 |
|
|
| Danaher Corporation (DHR) | 0.1 | $3.0M | +43% | 13k | 229.55 |
|
| Metagenomi (MGX) | 0.1 | $2.8M | 778k | 3.61 |
|
|
| Tuya Sponsered Ads (TUYA) | 0.1 | $2.8M | 1.6M | 1.79 |
|
|
| Smart Sh Global Ads (EM) | 0.1 | $2.8M | 3.9M | 0.70 |
|
|
| Ge Vernova (GEV) | 0.1 | $2.6M | 7.8k | 328.93 |
|
|
| Msci (MSCI) | 0.1 | $2.2M | NEW | 3.7k | 600.01 |
|
| Moody's Corporation (MCO) | 0.1 | $2.1M | +198% | 4.5k | 473.37 |
|
| Mogu Spon Ads (MOGU) | 0.1 | $1.8M | 848k | 2.17 |
|
|
| Ge Aerospace Com New (GE) | 0.1 | $1.7M | +80% | 10k | 166.79 |
|
| Bright Scholar Ed Hldgs Spon Ads New (BEDU) | 0.1 | $1.7M | 988k | 1.72 |
|
|
| Pacific Biosciences of California (PACB) | 0.1 | $1.7M | 919k | 1.83 |
|
|
| Joyy Ads Repstg Com A (YY) | 0.0 | $1.3M | 30k | 41.85 |
|
|
| Trane Technologies SHS (TT) | 0.0 | $864k | +210% | 2.3k | 369.35 |
|
| Dada Nexus Ads (DADA) | 0.0 | $847k | +16% | 700k | 1.21 |
|
| Pyxis Oncology Common Stock (PYXS) | 0.0 | $597k | 383k | 1.56 |
|
|
| Hello Group Ads (MOMO) | 0.0 | $413k | NEW | 54k | 7.71 |
|
| Lakeshore Biopharma Ord Shs New | 0.0 | $259k | NEW | 75k | 3.45 |
|
| Uxin Sponsored Ads (UXIN) | 0.0 | $89k | 19k | 4.63 |
|
|
| China Jo-jo Drugstores Shs New (CJJD) | 0.0 | $35k | 20k | 1.75 |
|
Past Filings by Hhlr Advisors
SEC 13F filings are viewable for Hhlr Advisors going back to 2018
- Hhlr Advisors 2024 Q4 filed Feb. 14, 2025
- Hhlr Advisors 2024 Q3 filed Nov. 14, 2024
- Hhlr Advisors 2024 Q2 filed Aug. 14, 2024
- Hhlr Advisors 2024 Q1 filed May 14, 2024
- Hhlr Advisors 2023 Q4 filed Feb. 14, 2024
- Hhlr Advisors 2023 Q3 filed Nov. 14, 2023
- Hhlr Advisors 2023 Q2 filed Aug. 14, 2023
- Hhlr Advisors 2023 Q1 filed May 15, 2023
- Hhlr Advisors 2022 Q4 filed Feb. 14, 2023
- Hhlr Advisors 2022 Q3 filed Nov. 14, 2022
- Hhlr Advisors 2022 Q2 filed Aug. 15, 2022
- Hhlr Advisors 2022 Q1 filed May 16, 2022
- Hhlr Advisors 2021 Q4 filed Feb. 14, 2022
- Hhlr Advisors 2021 Q3 filed Nov. 15, 2021
- Hhlr Advisors 2021 Q2 filed Aug. 16, 2021
- Hillhouse Capital Advisors 2021 Q1 filed May 17, 2021